Steven Cobourn
Director of Finance/CFO at NEXTCURE, INC.
Net worth: - $ as of 2024-03-30
Profile
Steven P.
Cobourn is currently the Chief Financial & Accounting Officer at NextCure, Inc. Prior to his current position, he served as the Chief Financial Officer at Vaccinex, Inc. from 2014 to 2018.
Before that, he held the position of Vice President-Finance & Treasurer at Otsuka America Pharmaceutical, Inc. from 2003 to 2014.
Mr. Cobourn completed his undergraduate degree at Drexel University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NEXTCURE, INC.
-.--% | 2024-03-28 | 0 ( -.--% ) | - $ | 2024-03-30 |
Steven Cobourn active positions
| Companies | Position | Start |
|---|---|---|
| NEXTCURE, INC. | Director of Finance/CFO | 2017-12-31 |
Former positions of Steven Cobourn
| Companies | Position | End |
|---|---|---|
| VACCINEXPAR | Director of Finance/CFO | 2017-12-31 |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Director of Finance/CFO | 2014-03-31 |
Training of Steven Cobourn
| Drexel University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VACCINEXPAR | Health Technology |
| Private companies | 2 |
|---|---|
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Health Technology |
| NextCure, Inc. |
- Stock Market
- Insiders
- Steven Cobourn
